Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Core EBITDA Growth

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 59.64-14.83-17.6213.0223.10

What is the latest Core EBITDA Growth ratio of AUROBINDO PHARMA ?

The latest Core EBITDA Growth ratio of AUROBINDO PHARMA is 59.64 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202459.64
Mar2023-14.83
Mar2022-17.62
Mar202113.02
Mar202023.10

How is Core EBITDA Growth of AUROBINDO PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 59.64
Positive
Mar2023 -14.83
Negative
Mar2022 -17.62
Negative
Mar2021 13.02
-43.64
Mar2020 23.1 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Core EBITDA Growth ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹63,667.3 Cr -4.2% -7.8% -12.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹399,249.0 Cr -1.3% -3.3% 8.3% Stock Analytics
DIVIS LABORATORIES ₹174,940.0 Cr -1.5% 0.8% 42.3% Stock Analytics
CIPLA ₹121,197.0 Cr -1.7% 2.3% -5.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,618.0 Cr -1.6% 8.4% 10.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,250.0 Cr -3.3% -1.4% 9.8% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-4.2%

-7.8%

-12.7%

SENSEX

1.6%

1%

7%


You may also like the below Video Courses